BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 24183322)

  • 1. Endogenous ligands of benzodiazepine binding site have inverse agonistic properties.
    Sliva J; Hess L; Votava M; Malek J
    Med Hypotheses; 2013 Dec; 81(6):1075-7. PubMed ID: 24183322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
    Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
    Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.
    Barbalho CA; Nunes-de-Souza RL; Canto-de-Souza A
    Brain Res; 2009 Apr; 1267():65-76. PubMed ID: 19268657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GABA
    Pitsikas N; Tarantilis PA
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33266149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties.
    Araujo F; Ruano D; Vitorica J
    J Pharmacol Exp Ther; 1999 Sep; 290(3):989-97. PubMed ID: 10454469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors.
    Brot MD; Akwa Y; Purdy RH; Koob GF; Britton KT
    Eur J Pharmacol; 1997 Apr; 325(1):1-7. PubMed ID: 9151931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
    Langen B; Egerland U; Bernöster K; Dost R; Unverferth K; Rundfeldt C
    J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative positioning of diazepam in the benzodiazepine-binding-pocket of GABA receptors.
    Tan KR; Baur R; Charon S; Goeldner M; Sigel E
    J Neurochem; 2009 Dec; 111(5):1264-73. PubMed ID: 19804380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans.
    Atack JR; Wafford KA; Street LJ; Dawson GR; Tye S; Van Laere K; Bormans G; Sanabria-Bohórquez SM; De Lepeleire I; de Hoon JN; Van Hecken A; Burns HD; McKernan RM; Murphy MG; Hargreaves RJ
    J Psychopharmacol; 2011 Mar; 25(3):314-28. PubMed ID: 20147571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of benzodiazepine inverse agonist FG 7142-induced anxiety syndrome by neurosteroids in mice.
    Reddy DS; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):665-81. PubMed ID: 9542718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
    McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
    Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of flumazenil and CGS 8216 on the anxiolytic-like properties of loreclezole.
    Dawson GR; Curnow R; Bayley P; Rambridge A; Tricklebank MD
    Eur J Pharmacol; 1994 Feb; 252(3):325-8. PubMed ID: 7909294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Anxiolytic" and "anxiogenic" benzodiazepines and beta-carbolines: effects on aggressive and social behavior in rats and squirrel monkeys.
    Weerts EM; Tornatzky W; Miczek KA
    Psychopharmacology (Berl); 1993; 110(4):451-9. PubMed ID: 7870916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
    Lewis RT; Blackaby WP; Blackburn T; Jennings AS; Pike A; Wilson RA; Hallett DJ; Cook SM; Ferris P; Marshall GR; Reynolds DS; Sheppard WF; Smith AJ; Sohal B; Stanley J; Tye SJ; Wafford KA; Atack JR
    J Med Chem; 2006 Apr; 49(8):2600-10. PubMed ID: 16610803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N,N'-dicyclohexylsulfamide and N,N'-diphenethylsulfamide are anticonvulsant sulfamides with affinity for the benzodiazepine binding site of the GABA(A) receptor and anxiolytic activity in mice.
    Wasowski C; Gavernet L; Barrios IA; Villalba ML; Pastore V; Samaja G; Enrique A; Bruno-Blanch LE; Marder M
    Biochem Pharmacol; 2012 Jan; 83(2):253-9. PubMed ID: 22056620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
    Behav Brain Res; 2005 Mar; 158(2):293-300. PubMed ID: 15698896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands.
    Pike A; Cook SM; Watt AP; Scott-Stevens P; Rosahl TW; McKernan RM; Pym LJ; Guiblin A; Moyes C; Sohal B; Atack JR
    Biopharm Drug Dispos; 2007 Sep; 28(6):275-82. PubMed ID: 17570124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological analysis of the effects of benzodiazepines on punished schedule-induced polydipsia in rats.
    Pellón R; Ruíz A; Lamas E; Rodríguez C
    Behav Pharmacol; 2007 Feb; 18(1):81-7. PubMed ID: 17218801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.